WEST PHARMACEUTICAL SERVICES INC 8-K

What Happened
West Pharmaceutical Services, Inc. announced on March 9, 2026 (via Form 8-K) that Eric M. Green, President, Chief Executive Officer and Chair of the Board, informed the board on March 6, 2026 of his intent to retire once his successor is hired to ensure a smooth transition. The Board has engaged a leading executive recruiting firm to conduct the search and expects the leadership transition to occur in the second half of 2026. The company also furnished a press release reaffirming its 2026 financial guidance previously provided in its February 12, 2026 earnings release.

Key Details

• Announcement date: March 9, 2026; Mr. Green notified the Board on March 6, 2026.
• Roles affected: Eric M. Green — President, CEO and Chair of the Board.
• Timing: Board expects the transition to occur in H2 2026 (after a successor is hired).
• Process: Board has retained a leading executive recruiting firm to assist with the CEO search.
• Disclosure: Press release (Exhibit 99.1) furnished on March 9, 2026; company reaffirmed its 2026 financial guidance.

Why It Matters
A CEO transition is a material leadership change that can affect strategy, operations and investor confidence. The company’s prompt disclosure, use of an executive search firm, and reaffirmation of 2026 guidance aim to reduce uncertainty for investors by signaling an orderly, planned handoff and continuity of financial expectations. Retail investors should watch for announcements of the successor and any updates to guidance or strategic priorities.